Pay in 4 interest-free payments of $5.45 Learn more
Ships within 48 hours · Estimated delivery Sep 23 - Sep 28
Meanwhile, cashier design should prioritize speed and certainty: instant deposit confirmations, estimated withdrawal times, and proactive alerts if further verification is needed
The study included adults considered obese or overweight with at least one weight-related health condition
MariTide, developed by Amgen, is a first-in-class antibody-peptide conjugate that combines GLP-1 receptor agonism with GIP receptor antagonism in a single molecule designed for once-monthly dosing
Back to Journals Clinical Ophthalmology Volume 19 GLP-1R Agonists Improve Ocular Surface Parameters in Type 2 Diabetes Mellitus Authors Ottonelli G, Gaeta A , Montericcio N , Tredici C, Ortfeldt V, Birtolo MF , Jaafar S , Mirani M , Di Maria A Received 17 June 2025 Accepted for publication 14 September 2025 Published 15 October 2025 Volume 2025:19 Pages 38293836 DOI Checked for plagiarism Yes Review by Single anonymous peer review Peer reviewer comments 2 Editor who approved publication: Dr Scott Fraser Giovanni Ottonelli, 1 Alessandro Gaeta, 2 Novella Montericcio, 3 Costanza Tredici, 1 Vittoria Ortfeldt, 4 Maria Francesca Birtolo, 4, 5 Simona Jaafar, 4, 5 Marco Mirani, 5 Alessandra Di Maria 1 1 Department of Ophthalmology, IRCCS Humanitas Research Hospital, Milan, 20089, Italy
US$ 27.33
US$ 24.80
US$ 22.12
US$ 28.14
US$ 29.10
US$ 26.04
US$ 22.51
US$ 24.08
